NMDA antagonists (Tennessee University)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameNMDA antagonists (Tennessee University)

Drug Alias NamePCP therapy (Univ of Tennessee)pentamidine analogs (Univ of Tennessee)CNS therapeutics (Tennessee University)anti-P carinii agents (Tennessee Univ)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionGlutamate [NMDA] receptor antagonists

TargetsGlutamate [NMDA] receptor

Therapy Area/IndicationsCentral Nervous System Diseases +[2]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesUniversity of Tennessee Memphis

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesUniversity of Tennessee Memphis

Active IndicationsN/A

Inactive IndicationsCentral Nervous System Diseases +[2]

Other Information

ATC CodeN/A